CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

BioMerieux shares rise after Q3 sales beat

By Reuters News

** Shares in BioMérieux BIOX.PA rise 4.4% after the company posted better-than-expected sales in the third quarter

** Q3 sales came at €1,042 million, up 8% year on year organically, above the company's compiled median consensus for sales of €1,007 million and organic growth of 5.9%

** Non-respiratory panels saw a 25% increase year-on-year, helped by demand related to the cyclosporiasis outbreak in the US

** J.P.Morgan notes higher organic growth across all divisions

** "The shares have had a decent run (+16%) into results on easing worries about a FY26 guidance cut and sector rotation but have still underperformed YTD (-18%)," JPM says

** Shares on track for best day since the beginning of August

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk